Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AbbVie Sales And Growth Increasingly Dominated By Humira

Apr 26 2013

Related Content

AbbVie CEO Emphasizes Humira Growth Plans, Potential Of HCV Program

Jan 03 2013

Europe’s CHMP Okays Xtandi, Erivedge And Spedra, But Rejects Xeljanz

Apr 26 2013

Related Companies

AbbVie Inc.

Abbott

Pfizer Inc.

Gilead Sciences, Inc.

Additional Topics

United States Europe Business Strategies BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window